Bisphosphonates: are they standard of care for the treatment of breast cancer?
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2007
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- 1117 Public Health and Health Services (FoR)
- Alendronate (MeSH)
- Bone Density Conservation Agents (MeSH)
- Bone Neoplasms (MeSH)
- Breast Neoplasms (MeSH)
- Clodronic Acid (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Randomized Controlled Trials as Topic (MeSH)
published in
- British Journal of Cancer Journal